Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11528 posts found.

Alnylam and Sanofi close research phase of 2014’s $700m RNAi rare disease partnership

April 8, 2019 Research and Development, Sales and Marketing Alnylam, Genzyme, Sanofi, pharma, rare disease

Alnylam and Sanofi have announced their intention to bring to an end the research and option phase of a $700 …
News

Osteoporisis risk in over half of European women over 70, three-quarters not treated, Amgen study finds

April 8, 2019 Research and Development, Sales and Marketing Amgen, Europe, UK, bones, osteoporosis, pharma, real world data, real-world data

A new study from Amgen analysing real-world data has revealed that more than half of European women over 70 years …
News

€100m expansion of J&J’s Limerick manufacturing facility to bring up to 300 jobs

April 8, 2019 Manufacturing and Production, Sales and Marketing

Johnson & Johnson has revealed plans to expand its existing Vision Care facilities at the National Technology Park in Limerick, …
News

Merrimack shuts down development of investigational cancer drug, staff cuts to follow

April 8, 2019 Research and Development, Sales and Marketing cacner, merrimack, oncology, pharma

Merrimack Pharmaceuticals has taken the decision to terminate development of its antibody-directed nanotherapeutic cancer therapy MM-310 in the treatment of …
News

Top Ten most popular articles on Pharmafile.com this week!

April 5, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, AstraZeneca, Northern Ireland, Novartis, Placebo, UK, brexit, pharma

As Brexit looms, pharma trade lobby the ABPI called for a ban on exports of medicines in the case of …
News

FDA approves Pfizer’s Ibrance for advanced male breast cancer

April 5, 2019 Medical Communications, Sales and Marketing Cancer, FDA, Pfizer, breast cancer, ibrance, male breast cancer, pharma

The FDA has chosen to expand the indications of Pfizer’s Ibrance (palbociclib), the company announced, approving the CDK4/6 inhibitor in …
News

BMS Opdivo/Yervoy recommended for untreated kidney cancer via Cancer Drugs Fund

April 5, 2019 Medical Communications, Sales and Marketing CDF, Cancer, Cancer Drugs Fund, Kidney cancer, NICE, UK, Yervoy, opdivo

NICE has revealed it is recommending that Bristol-Myers Squibb’s Opdivo (nivolumab), in combination with Yervoy (ipilimumab), be made available to …
News

Crescendo Biologics selects current CFO Theodora Harold as new CEO

April 4, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CEO, Cambridge, Crescendo Biologics, Dr Peter Pack, Theo Harold, cfo

Cambridge, UK-based Crescendo Biologics have said current Chief Financial Officer (CFO) Theodora Harold will take over from Dr Peter Pack …
Appointment

Sorrento Therapeutics seek $1 billion from billionaire biotech investor Patrick Soon-Shiong

April 4, 2019 Business Services, Sales and Marketing Abraxane, Celgene, Cynviloq, Patrick Soon-Shiong, Sorrento, lawsuits

Sorrento Therapeutics is seeking $1 billion in damages from billionaire biotech investor Patrick Soon-Shiong, owner of US newspaper the LA …
News

European approval for Pfizer’s Vizimpro in first-line non-small cell lung cancer

April 4, 2019 Sales and Marketing Cancer, Europe, Pfizer, Vizimpro, lung cancer, non small cell lung cancer, non-small cell lung cancer, pharma

The European Commission has awarded marketing approval to Pfizer’s tyrosine kinase inhibitor (TKI) Vizimpro (dacomitinib), it has emerged, as a …
News

Sangamo and Pfizer’s gene therapy increases FVIII activity in severe haemophilia A in early study

April 3, 2019 Research and Development, Sales and Marketing Pfizer, Sangamo, haemophilia, pharma

Sangamo Therapeutics and Pfizer have unveiled new Phase 1/2 data for their jointly developed investigational gene therapy SB-525, demonstrating that …
News

Novartis’ Cosentyx approved in China for plaque psoriasis

April 2, 2019 Manufacturing and Production, Sales and Marketing China, Cosentyx, Novartis, pharma, psoriasis

Novartis has revealed that its interleukin-17A (IL-17A) Cosentyx (secukinumab) has been authorised for use in China in the treatment of …
News

Teva’s Ajovy injection secures EU approval for the prevention of migraine

April 2, 2019 Manufacturing and Production, Sales and Marketing EU, Europe, Teva, ajovy, migraine, pharma

Teva has announced that its calcitonin gene-related peptide (CGRP) inhibitor Ajovy (fremanezumab) has been awarded marketing authorisation by the European …
News

Artios Pharma name experienced oncologist as company’s new CMO

April 1, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Artios Pharma, CMO, Cancer, DDR, oncology

British biotech Artios Pharma have appointed experienced oncologist Dr Ian Smith, as the company’s new Chief Medical Officer (CMO). Dr …
Appointment

How I learned to stop worrying and love the placebo effect

April 1, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing clinical trials, feature, pharma, placebo effect

Louis Goss talks to Harvard Medical School placebo expert Dr Ted Kaptchuk in asking what the placebo effect means for …
Feature
The Gateway to Local Adoption Series

Latest content

From lab breakthrough to NHS treatment: Getting innovative therapies to patients

September 5, 2026

Five Facts about NHS and primary care

September 5, 2026

Clinical trials don’t just have a recruitment problem, they have an enrolment protection problem.

September 5, 2026

AI in pharma: From lab development to patient impact

September 5, 2026

Back to basics: X-ray inspection in pharmaceutical and medical device production

September 5, 2026